Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments
September 10, 2018 16:05 ET
|
Avid Bioservices, Inc
-- Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Multiple Projects Advanced During the Quarter -- -- Initiated Operations of New Process Development Laboratories -- TUSTIN,...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
September 05, 2018 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices to Present at Upcoming Investor Conferences
August 29, 2018 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition
August 28, 2018 08:05 ET
|
Avid Bioservices, Inc
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- ...
Avid Bioservices to Exhibit at the Bioprocessing Summit 2018
August 08, 2018 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer
July 17, 2018 08:05 ET
|
Avid Bioservices, Inc
-- Senior Executive with Extensive Financial Leadership Experience Further Strengthens Management Team; Company Also Adds Senior Director of Business Development for Western Region to Support Client...
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments
July 16, 2018 16:05 ET
|
Avid Bioservices, Inc
-- Company Records Fiscal Year 2018 Revenue of $53.6 Million -- -- Committed Backlog Increases to $57.8 Million (ASC 605) -- -- Customer Base Expanded and Diversified -- -- Key Appointments...
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018
July 09, 2018 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index
June 25, 2018 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Participate at BIO International Convention 2018
May 29, 2018 08:05 ET
|
Avid Bioservices, Inc
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- --...